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Abstract
Exotoxins, including the hemolysins known as the alpha (a) and beta (b) toxins, play an important role in the pathogenesis
of Staphylococcus aureus infections. A random transposon library was screened for S. aureus mutants exhibiting altered
hemolysin expression compared to wild type. Transposon insertions in 72 genes resulting in increased or decreased
hemolysin expression were identified. Mutations inactivating a putative cyclic di-GMP synthetase and a serine/threonine
phosphatase (Stp1) were found to reduce hemolysin expression, and mutations in genes encoding a two component
regulator PhoR, LysR family transcriptional regulator, purine biosynthetic enzymes and a serine/threonine kinase (Stk1)
increased expression. Transcription of the hla gene encoding a toxin was decreased in a Dstp1 mutant strain and increased
in a Dstk1 strain. Microarray analysis of a Dstk1 mutant revealed increased transcription of additional exotoxins. A Dstp1
strain is severely attenuated for virulence in mice and elicits less inflammation and IL-6 production than the Dstk1 strain. In
vivo phosphopeptide enrichment and mass spectrometric analysis revealed that threonine phosphorylated peptides
corresponding to Stk1, DNA binding histone like protein (HU), serine-aspartate rich fibrinogen/bone sialoprotein binding
protein (SdrE) and a hypothetical protein (NWMN_1123) were present in the wild type and not in the Dstk1 mutant.
Collectively, these studies suggest that Stk1 mediated phosphorylation of HU, SrdE and NWMN_1123 affects S. aureus gene
expression and virulence.
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Introduction
Invasive bacterial infections remain a significant cause of
morbidity and mortality in humans [1]. Staphylococcus aureus is
among the most common human pathogens. Although 20% of the
population are asymptomatically colonized with S. aureus in the
skin, upper respiratory or gastrointestinal tracts, S. aureus is also the
leading cause of invasive infections in both community and in
healthcare settings [2,3,4]. Clinical manifestations of S. aureus
range from superficial skin infections to severe or deep-seated
infections such as pneumonia, bacteremia, osteomyelitis, endocar-
ditis and toxic shock [5].
A number of virulence factors that include hemolysins,
exotoxins, leukocidins, superantigens, capsule and secreted
enzymes allow S. aureus to overcome host defenses (for recent
reviews, see [6,7]). S. aureus lysis of red blood cells is primarily
mediated by the hemolysins known as alpha (a), beta (b) and delta
(d) toxins. The a toxin encoded by the hla gene is important for S.
aureus pneumonia, sepsis, septic arthritis, brain abscess and corneal
infections [8,9,10,11,12,13]. This 33kDa pore forming toxin is
secreted by majority of S. aureus clinical isolates and is active
against a wide range of mammalian cells, with especially marked
activity against rabbit erythrocytes [14,15]. In addition to its pore
forming ability, a toxin induces the release of cytokines and
chemokines such as IL-6, IL-1b, IL-1a, IL-8, TNF-a, KC and
MIP-2 [9,16,17,18,19,20]. Immunization with inactive a toxin was
recently shown to protect mice against lethal S. aureus pneumonia
[21,22,23]. These observations emphasize the importance of a
toxin in S. aureus infections.
Certain strains of S. aureus also secrete beta (b) toxin, a 35kDa
sphingomyelinase encoded by the hlb gene [24,25,26]. In contrast
to a toxin, b toxin is highly hemolytic for sheep but not for rabbit
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erythrocytes [27]. Hemolytic activity of b toxin is enhanced after
incubation at temperatures below 10uC, hence this toxin is often
referred to as the ‘hot-cold’ hemolysin [24,27]. The importance of
b toxin has been demonstrated in S. aureus infections of the human
lung and cornea, and an ability to inhibit the ciliary activity of
nasal epithelial cells has been described [28,29,30]. The presence
of a cleavable signal sequence in the N-terminal region of a and b
toxins suggests that they are secreted by the general secretory (sec)
pathway (for a review, see [31]). Although not much is known
about the Sec pathway in S. aureus, this pathway has been
extensively characterized in B. subtilis and E. coli [32,33].
Delta (d) hemolysin or toxin is a 26 amino acid peptide encoded
by the hld gene [34,35]. This toxin is produced by 97% of S. aureus
isolates and lyses erythrocytes, a variety of mammalian cells and
sub-cellular structures such as membrane bound organelles,
spheroplasts and protoplasts [36,37]. In contrast to the a and b
toxins, d toxin does not possess a cleavable signal sequence [27],
and its mechanism of secretion is not completely understood.
Because the structural gene for d toxin is encoded within the RNA
molecule (RNAIII) that activates transcription of a number of
virulence factors such as a toxin, enterotoxins, and toxic shock
syndrome toxin, and represses the transcription of cell surface
proteins such as protein A, the precise contribution of d toxin to S.
aureus virulence is not known [38,39].
Despite the importance of S. aureus as a pathogen, our
understanding of the molecular events that enable the organism
to make the transition from a commensal state into an invasive
pathogen is limited. Mechanisms that facilitate S. aureus infiltration
into deeper tissues with subsequent dissemination and invasion of
multiple organs remain to be completely understood. However, the
diverse array of host niches encountered by S. aureus suggests that the
pathogen efficiently adapts to changing environments to survive and
establish successful infections. Pathogenic bacteria commonly utilize
signaling systems to adapt, survive and invade a variety of host
niches [40,41,42]. Signaling is primarily achieved through revers-
ible phosphorylation of proteins, and these modifications are the
most critical of the 200 different types of post-translational
modifications [43,44]. A number of two-component systems
(TCS) and one component transcriptional regulators regulate the
transcription of S. aureus virulence genes [45,46]. These include the
complex accessory gene regulatory system (agrABCD) that up-
regulates the expression of superantigens, cytotoxins, and secreted
enzymes, and represses the transcription of cell-wall proteins such as
protein A and fibronectin binding proteins [38,45]. Other TCS
known as SaeR/SaeS and ArlR/ArlS also regulate the transcription
of a (hla) and b (hlb) toxins in S aureus [47,48,49,50]. The
staphylococcal accessory regulator known as SarA binds to
conserved promoter regions known as ‘Sar boxes’ for transcriptional
regulation. Sar homologues such as SarT and Rot are also described
to repress transcription of hla [51,52,53,54,55].
In this study, we screened a random transposon library for
mutants that showed either an increase or decrease in hemolysin
expression compared to wild type (WT). Our studies identified 72
genes that affect hemolysin expression in S. aureus and include
signaling enzymes commonly found in eukaryotes. We further
demonstrate that these eukaryotic-like signaling enzymes affect a
toxin (hla) transcription and S. aureus virulence.
Results
Identification of genes that regulate hemolytic activity of
S. aureus
Previous studies have established that hemolysins are important
for infections caused by S. aureus. To identify novel factors that
regulate hemolysin expression in S. aureus, we screened a transposon
insertion library for mutants that showed either an increase or
decrease in hemolytic activity compared to the wild type (WT) strain.
The transposon library was obtained as a kind gift from Chiron
Corporation/Novartis Vaccines (CMCC #51963, patent WO/
2004/018624). This library consists of 6,725 individual, random
transposon Tn5EZ mutants for which the insertion sites of the
transposons in the S. aureus genome are known (see patent WO/
2004/018624 entitled ‘Random transposon insertion in Staphyloco-
ccus aureus and use thereof to identify essential genes’ at
http://www.wipo.int/pctdb/en/wo.jsp?WO = 2004%2F018624&IA
=WO2004%2F018624&DISPLAY = DESC). The Tn5EZ mutants
were derived from S. aureus RN4220, and all 6,725 mutants are
contained on individual, 96-well microtiter plates. Although RN4220
has the genes encoding a (hla), b (hlb), and d (hld) toxins, an extra
adenine residue in the 39 end of the gene encoding agrA decreases a
and d toxin expression (for details, see[56]). As expression of b toxin is
not tightly regulated by agr [56], hemolytic activity due to this toxin is
seen in RN4220. We hypothesized that screening the transposon
library for mutants with altered hemolytic activity would enable us to
identify genes that affect a and d toxin expression despite decreased agr
regulation, and also identify genes that regulate b toxin expression.
To identify mutants that showed altered hemolytic activity, we
used a 48-well prong to transfer individual colonies onto sheep
blood agar plates (SBA). These plates were incubated at 37uC
overnight. Subsequently, the plates were transferred to 4uC
overnight, and colonies that exhibited increased or decreased
hemolytic activity after incubation at 37uC and 4uC were
identified by visual screening (see Fig. 1, A and B for a
representative plate). Analysis of the selected mutants on SBA
was repeated to confirm the reproducibility of the hemolytic
phenotype. Our studies indicate that transposon insertions in (a) 13
genes abolished hemolytic activity (No Hemolysis, NH), (b) 25
genes conferred decreased hemolysis (Less Hemolysis, LH), (c) 26
genes caused a moderate increase in hemolysis (Moderately hyper-
hemolysis, MH), and (d) 8 genes conferred hyper-hemolysis (Hyper
hemolysis, HH) when compared to the WT and most other
Tn5EZ mutants on the same SBA plate (Table 1–4, Fig. 1 A
and B).
As expected, transposon insertions in the hlb gene encoding b
toxin, and a few known hemolysin activators such as agrA [38,45],
saeR [47,48] and ccpA [57] decreased and/or abolished hemolytic
activity in RN4220 (Table 1 and 2). Likewise, a Tn5EZ insertion
in the previously described hemolysin repressor rot increased
hemolytic activity (Table 3 and [55]). As the transposon library did
not contain insertions in the structural genes for a toxin (hla), d
toxin (hld) and other known hemolysin regulators such as sarART
and agrBC [45], these genes were not identified in the above
analysis. A transposon insertion in the gene encoding acetate
kinase down-regulated hemolysin expression; this may be due to
decreased synthesis of acetyl phosphate, an intracellular signal for
phosphorylation of two component response regulators (for a
review, see [58]). Taken together, the above findings validate our
screen for altered hemolysin expression in S. aureus. Importantly,
our studies also identified a number of novel genes that regulate
hemolysin expression of S. aureus (Table 1–4). Transposon
insertions in the two component regulator PhoR, purine
biosynthetic gene purF, a gene predicted to encode a transcrip-
tional regulator of the LysR family (SA2555), and the serine/
threonine kinase gene stk1 increased the hemolytic phenotype (see
Table 3 and 4). As the increase in hemolytic activity of these
mutants was observed at 37uC, we hypothesized that this may be
due to an increase in a and/or d toxin, as b toxin-mediated lysis of
red blood cells is primarily seen after incubation at temperatures
S. aureus Virulence
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below 10uC [24,27]. Therefore, we compared hemolytic activity of
these strains on rabbit blood agar (RBA), as a toxin demonstrates a
.1000 fold increase in lysis of rabbit erythrocytes compared to
sheep erythrocytes, whereas b toxin does not lyse rabbit
erythrocytes [59]. Lysis of rabbit red blood cells (rRBC) was
observed in strains with Tn5EZ insertions in SA2555, purF and
stk1, in contrast to WT RN4220 (Fig. 1C), suggesting that these
loci repress a toxin expression. As expected, the NH and LH
strains did not demonstrate any difference in hemolysis on RBA
compared to WT RN4220 (data not shown).
A serine/threonine kinase and phosphatase regulate
hemolysin expression in S. aureus
The transposon screen indicated that an insertion in stk1 confers
an increase in S. aureus hemolysin activity (Table 3). Previous
studies from our laboratory have identified that homologues of stk1
regulate hemolysin expression in the gram-positive human
pathogen group B streptococcus [60,61]. Therefore, we were
interested in characterizing the role of Stk1 and its cognate serine/
threonine phosphatase Stp1 in the regulation of hemolysin
expression and virulence of S. aureus. To confirm that stk1 and
Figure 1. S. aureus transposon mutants showing increased or decreased hemolysis. Hemolytic activity is represented by the zone of
clearing around the colonies on the sheep blood agar plates. (A) and (B) represent the same sheep blood agar (SBA) plate. Forty-eight random TN5EZ
mutants of S. aureus were stamped on a SBA plate and incubated O/N at 37uC. The plate was then incubated at 4uC O/N. (A) shows hemolysin activity
after the 37uC incubation and (B) represents the same plate after the 4uC incubation. The wild type strain (WT, RN4220) was spotted as a control. Note
that a few mutants showed hyper-hemolysis (HH), moderately hyper-hemolysis (MH) or lower hemolysis (LH) compared to WT in both A and B. These
mutants were chosen for further analysis (Table 1–4). (C) Strains with transposon TN5EZ insertions in SA2555 (putative lysR family regulator), purF and
stk1 show a marked increase in hemolytic activity compared to WT RN4220 on rabbit blood agar (RBA).
doi:10.1371/journal.pone.0011071.g001
S. aureus Virulence
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Table 1. TN5EZ insertions that abolished S. aureus hemolysin activity.
# of mutants* Hemolysis Gene/Locus Function or predicted function
2 NH SA0014 Modified GGDEF guanylate cyclase/cyclic diGMP synthetase
1 NH SA0101 Ornithine cyclodeaminase
2 NH SA0164 Gramicidin S synthetase 2 – Non-ribosomal peptide synthetase
1 NH SA0403 Transcriptional antiterminator, BglG family
4 NH saeR Two-component regulator SaeR
1 NH mnhE Na/H antiporter, MnhE component
1 NH fmt Methionyl-tRNA formyltransferase
1 NH infB Translation initiation factor IF-2
1 NH dapA Dihydrodipicolinate synthase - aspartate family
2 NH hlb Phospholipase C, Fatty acid and lipid metabolism
2 NH SA2072 ATP-dependent RNA helicase, DEAD/DEAH box family
1 NH atpF ATP synthase F0, B subunit
1 NH SA0495 Hypothetical protein
*NH represents no hemolysis compared to WT and most other Tn5EZ mutants on sheep blood agar (also see Fig. 1). # of mutants represents the number of individual
transposon insertions in the same gene or loci that alter hemolysin activity.
doi:10.1371/journal.pone.0011071.t001
Table 2. TN5EZ insertions that reduced S. aureus hemolysin activity.
# of mutants* Hemolysis Gene/Locus Function or predicted function
1 LH SA0466 Membrane protein, putative
1 LH bioD Dethiobiotin synthase - Biosynthesis of cofactors
2 LH SA0555 Peptidase, M41 - Degradation of proteins, peptides,
1 LH SA0635 Lipoate-protein ligase A - Protein modification
1 LH SA0762 Hemolysin, putative -
3 LH gcvH Glycine cleavage system H protein - energy metabolism
1 LH SA0958 General stress protein 13
1 LH SA1049 1,4-dihydroxy-2-naphthoate octaprenyltransferase, putative
1 LH SA1220 Fibronectin-binding protein A-related
2 LH SA1294 Metallo-beta-lactamase superfamily protein
1 LH glpD Aerobic glycerol-3-phosphate dehydrogenase
1 LH SA1563 2-oxoisovalerate dehydrogenase, lipoamide dehydrogenase,
1 LH secDF Protein-secretion, membrane protein, SecDF family
1 LH SA1751 DHH family protein, putative
2 LH ackA Acetate kinase - fermentation
1 LH ccpA Catabolite control protein - DNA interactions
1 LH agrA Accessory gene regulator protein A
1 LH SA2027 Hypothetical protein - not conserved
9 LH atpDGA ATP synthase F1, beta, gamma and alpha subunits -
1 LH SA2271 Molybdenum ABC transporter, permease protein - cations
1 LH SA2375 Transporter - unknown substrate
1 LH SA2534 NAD(P)H-flavin oxidoreductase
1 LH SA2572 Cation-transporting atpase, E1-E2 family
1 LH SA2624 Acetyl-CoA synthetase, putative
3 LH SA2735 Chromosome partioning protein, ParB family
*LH represents lower hemolysis compared to WT and most other Tn5EZ mutants on sheep blood agar (also see Fig. 1).
doi:10.1371/journal.pone.0011071.t002
S. aureus Virulence
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stp1 regulate a toxin expression, phage w11 [62] was used to
transduce the Tn5EZ insertions in stk1 (Table 3) and stp1 from the
transposon library in RN4220 into the virulent strain of S. aureus
known as Newman. S. aureus Newman is proficient in expression of
a and d toxin but deficient for b toxin due to the insertion of a
prophage in hlb [63]. A comparison of hemolytic activity of these
strains indicated that a Tn5EZ insertion in stp1 (Newman 53E12)
decreased hemolytic activity, whereas a Tn5EZ insertion in stk1
(Newman 60C1) increased hemolytic activity compared to WT
Newman (Fig. 2A).
To further establish the role of Stp1 and Stk1 on hemolysin
expression and to examine their role in virulence of S. aureus, allelic
exchange mutants (AEM) were constructed. To this end, the
coding sequences of stp1 and stk1 were replaced with genes that
Table 3. TN5EZ insertions that increased S. aureus hemolysin activity.
# of mutants* Hemolysis Gene/Locus Function or predicted function
2 MH gyrA DNA gyrase, A subunit
9 MH SA0007 YjeF-related protein, C-terminus - unknown function
3 MH hutH Histidine ammonia-lyase
1 MH SA0216 Hypothetical protein
1 MH SA0237 Alcohol dehydrogenase, zinc-containing
1 MH SA0311 Sodium:solute symporter - Transport and binding proteins
1 MH geh Lipase precursor, interruption - disrupted reading frame
6 MH ksgA Dimethyladenosine transferase
1 MH SA0713 Hypothetical protein - not conserved
1 MH fruB 1-phosphofructokinase - Glycolysis/gluconeogenesis
1 MH SA1021 Multidrug-efflux transporter, putative
5 MH purL Phosphoribosylformylglycinamidine synthase II
1 MH SA1096 TRK system potassium uptake protein TrkA, putative - cations
1 MH pdhD Pyruvate dehydrogenase, E3 component,
2 MH stk1 Protein kinase - regulatory functions - protein interactions
1 MH SA1309 Pyruvate ferredoxin oxidoreductase, beta subunit,
1 MH SA1472 Pathogenicity protein, putative
2 MH era GTP-binding protein Era - small molecule interactions
1 MH SA1740 Two component DNA-binding regulator, PhoP
1 MH rot Virulence factor regulator protein
3 MH fumC Fumarate hydratase, class II - TCA cycle
2 MH pcrA PcrA protein - DNA replication, recombination, and repair
1 MH hutU Urocanate hydratase - Amino acids and amines
1 MH SA2308 Transcriptional regulator, RpiR family
9 MH SA2737 Glucose inhibited division protein A
12 MH thdF Thiophene and furan oxidation protein ThdF - detoxification
MH represents moderately hyper-hemolysis compared to WT and other Tn5EZ mutants.
doi:10.1371/journal.pone.0011071.t003
Table 4. TN5EZ insertions that significantly increased S. aureus hemolysin activity.
# of mutants* Hemolysis Gene/Locus Function or predicted function
3 HH SA0704 Iron compound ABC transporter, ATP-binding protein
5 HH purF Amidophosphoribosyltransferase - Purine biosynthesis
2 HH ptsl Phosphoenolpyruvate-protein phosphotransferase
2 HH pnp Polyribonucleotide nucleotidyltransferase - Degradation of RNA
1 HH SA2555 Transcriptional regulator, LysR family - DNA interactions
1 HH SA2113 Transcription termination factor Rho - transcription factors
1 HH SA2348 QacA subfamily/drug transporter, putative
1 HH SA1281 Membrane-associated zinc metalloprotease,
*HH represents hyper-hemolysis compared to WT and most other Tn5EZ mutants on sheep blood agar (also see Fig. 1).
doi:10.1371/journal.pone.0011071.t004
S. aureus Virulence
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conferred either chloramphenicol (Cm, [64]) or kanamycin
resistance (Kn, [65]) in S. aureus RN4220 and subsequently
transduced into S. aureus Newman (see Methods for details). We
then compared the hemolytic activity of WT to isogenic Dstp1 and
Dstk1 strains. Consistent with the transposon mutants (Fig. 2A),
hemolytic activity was lower in a Dstp1 mutant constructed by
allelic exchange and higher in the Dstk1 mutant, compared to WT
Newman (Fig. 2B). Although changes in hemolysin expression are
often observed in S. aureus due to spontaneous nonsense mutations
in the agr regulatory system [56,66], a comparison of the DNA
sequence of the agr locus (agrABCD) between WT Newman and the
isogenic Dstp1 and Dstk1 strains did not indicate the presence of
any spontaneous agr mutations (data not shown). Similar changes
in hemolysin expression were also observed in Dstk1 and Dstp1
mutants derived from WT S. aureus RN6390 (data not shown).
Taken together, these data indicate that Stp1 and Stk1 oppositely
regulate hemolytic activity of S. aureus.
Role of Stp1 and Stk1 in transcription of hla
We next examined whether the absence of Stp1 or Stk1 affected
the transcription of the gene encoding a toxin. To test this
possibility, RNA was isolated from three independent biological
replicates of WT S. aureus Newman and isogenic Dstp1 and Dstk1
strains grown in tryptic soy broth (TSB) to an optical density
(OD600) of 0.6 (exponential phase) or ,3.0 (post-exponential
phase), and quantitative real time PCR (qRT-PCR) was
performed as described [67]. The housekeeping gene rpoD was
used to normalize transcription of hla and hld by the comparative
CT method [68]. In these studies, we also compared transcription
of the gene encoding d toxin (hld), the Agr-repressed gene encoding
Protein A (spa) and agrA. We observed that transcription of hla was
approximately 2-fold lower in the Dstp1 mutant and significantly
higher (6.4 fold) in the Dstk1 mutant compared to WT, but only
during post-exponential phase growth (Table 5, P,0.05, student’s
t test). Under these conditions, transcription of hld, spa and agrA
were not significantly different between WT, Dstp1 and Dstk1
mutants (Table 5). Given that AgrA positively regulates transcrip-
tion of hla and hld, and negatively regulates spa transcription during
post-exponential phase growth of S. aureus, our results suggest that
Stp1 and Stk1 regulation of a toxin transcription is independent of
global Agr regulation. To confirm that the change in hla
transcription in Dstp1 and Dstk1 correlated with altered a toxin
protein levels, we performed quantitative western blots as
described ([21], also see Methods). Four independent experiments
indicated that extracellular or secreted a toxin was 1.7–2 fold
higher in the Dstk1 strain compared to WT S. aureus Newman
(Fig. 3A). Decreased a toxin levels were observed in the Dstp1
strain compared to WT Newman (Fig. 3B). However, intracellular
a toxin levels in Dstp1 and Dstk1 mutants were not consistently
different from that of WT (data not shown).
To confirm that the change in hemolytic activity of the Dstp1
and Dstk1 strains was due to the absence of these genes, we
performed complementation studies. The genes encoding stp1 and
stk1 were PCR-amplified and cloned into the complementation
vector pDCerm to generate pStp1 and pStk1, respectively (Table
S1). The complementing plasmids pStp1 and pStk1, and the
vector pDCerm, were electroporated into the RN4220 Dstp1 and
Dstk1 strains. Subsequently, using w-11, these plasmids were
transduced into Newman Dstp1 and Dstk1 strains. qRT-PCR and
quantitative western blots confirmed that a toxin was restored to
WT levels in both the Dstp1 and Dstk1 strains containing the
complementing plasmids (Table 5, Fig. 3A & B). Hemolytic
activity was restored to WT levels in both the Dstp1 and Dstk1
strains containing the complementing plasmids (see Dstp1/pStp1
and Dstk1/pStk1 in Fig. 3C), in contrast to those containing only
the vector pDCerm. These data confirm that Stp1 and Stk1
regulate expression of a toxin in S. aureus.
Figure 2. A serine/threonine phosphatase and kinase oppo-
sitely regulate hemolytic activity of S. aureus. (A) A transposon
(Tn5EZ) insertion in stp1 (53E12) decreased hemolytic activity whereas
the strain with the Tn5EZ insertion in stk1 (60C1) increased hemolytic
activity compared to the isogenic WT Newman. (B) shows hemolytic
activity of Newman WT, Dstp1 and Dstk1 strains on sheep blood agar.
Note that hemolytic activity is decreased in the Dstp1 strain and
increased in a Dstk1 mutant compared to WT Newman.
doi:10.1371/journal.pone.0011071.g002
Table 5. Transcription of hla is decreased in S. aureus Dstp1
and increased in Dstk1 mutants.
Relative Gene Expression#
hla (a toxin) hld (d toxin) agrA spa
Dstp1 0.3160.15* 0.7860.53 0.5560.18 2.061.92
Dstk1 6.4261.98* 1.3360.09 1.1960.32 1.3960.47
Dstp1/pStp1 1.560.5 NT NT NT
Dstk1/pStk1 2.060.5 NT NT NT
#qRT-PCR was performed as described in Methods. Gene expression is denoted
as fold difference relative to the WT S. aureus strain Newman. Standard
deviation is indicated. NT indicates not tested.
*indicates statistically significant, P values,0.05, 2 tailed t test.
doi:10.1371/journal.pone.0011071.t005
S. aureus Virulence
PLoS ONE | www.plosone.org 6 June 2010 | Volume 5 | Issue 6 | e11071
Microarray analysis
The change in hla transcription observed in the Dstp1 and the
Dstk1 strains (Table 5) prompted us to examine global changes in
gene expression during post-exponential phase growth
(OD600,3.0). Transcriptional profiling analysis was performed
on RNA isolated from WT Newman and isogenic Dstp1 and Dstk1
mutants, and the results are shown in Table S2. These results
confirmed that stk1 expression was similar to WT in the Dstp1
strain but was 200-fold lower in the Dstk1 mutant (Table S2).
Similarly, stp1 expression was 100-fold decreased in the Dstp1
strain but similar to WT in the Dstk1 mutant (Table S2). A
comparison of gene expression between WT and Dstp1 or Dstk1
indicated that 32 genes were up-regulated and 43 genes were
down-regulated in the Dstk1 strain, whereas 84 genes were
Figure 3. Extracellular a toxin is decreased in a Dstp1 mutant and increased in a Dstk1 mutant compared to WT Newman. (A) and (B)
Quantitative western blots for a toxin were performed on equal amounts of extracellular protein from S. aureus WT (Newman), Dstp1, Dstk1 and the
complemented strains. As a control, 1mg purified a toxin (Sigma Chemical Co, USA) was included in these assays. Secreted or extracellular a toxin is
higher in a Dstk1 mutant and lower in a Dstp1 mutant compared to WT Newman. Two independent Dstp1 cultures were examined in Panel B. Note
that a toxin is restored to WT levels in the complemented Dstk1 (Dstk1/pStk1) and Dstp1 strains (Dstp1/pStp1), respectively. (C) shows hemolytic
activity of complemented Dstp1 and Dstk1 strains. Note that decreased hemolytic activity in a Dstp1 mutant is restored to WT levels in the
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up-regulated and 55 genes were down-regulated in the Dstp1 strain
(Table S2). As expected, transcription of a toxin was decreased in
the Dstp1 mutant and increased in the Dstk1 mutant. Interestingly,
transcription of a number of other exotoxins including LukF and
LukS were increased in a Dstk1 background (2.0–4.8 fold, Table
S2) whereas transcription levels of these genes was similar to the
WT in the Dstp1 strain. In contrast, transcription of genes
encoding capsular polysaccharide biosynthetic enzymes was 2.0–
2.5 fold increased in the Dstp1 mutant and decreased in the Dstk1
mutant. A comparison of genes that regulate hemolysin activity
(Table 1–4) to those observed in the microarray (Table S2)
indicated that genes important for hemolysin activity, such as
FruB, SACOL0495 and SACOL2072 (see ** in Table S2), showed
decreased expression in the Dstp1 mutant. Conversely, dapA
encoding dihydrodipicolinate synthase, that is also important for
hemolysin expression (Table 1), showed a modest increase in
transcription only in the Dstp1 mutant (see * in Table S2).
Surprisingly, decreased transcription of genes important for
hemolytic activity, i.e. FruB and the transcriptional anti-termina-
tor SACOL0403 (Table 3), were observed in the Dstk1 mutant (see
# in Table S2). Whether altered transcription of these genes
contributes to the change in hemolytic activity in Dstp1 and Dstk1
(Fig. 2) mutant strains has yet to be established.
Stp1 is essential for S. aureus virulence
The virulence of Dstp1 and Dstk1 mutants was compared with
WT using the mouse sepsis model of infection described previously
[69]. Six week-old female C57BL/6J mice (n = 10) were inoculated
intravenously with 2–56107 colony-forming units (CFU) of WT,
Dstp1 or Dstk1 strains as described [69]. Kaplan-Meier survival
curves shown in Fig. 4A indicate that 100% of mice infected with
WT S. aureus Newman succumbed to infection, whereas 90% of
the mice infected with a Dstp1 mutant survived the infection (P
value,0.0001, log rank test). Similar results was also observed
with the Newman stp1::TN5EZ strain (data not shown). Although
the mice infected with a Dstk1 mutant did not show a significant
difference in survival compared to the WT (P value = 0.44), a large
number of abscesses were observed in the kidneys of mice infected
with this strain (Fig. 4B). In contrast, the kidneys obtained from
mice infected with a Dstp1 mutant showed no visible abscesses
(Fig. 4B). Histological examination of infected kidneys at five days
post-inoculation indicated the presence of massive abscesses and
necrotic tissue surrounding bacterial microcolonies in mice
infected with WT or a Dstk1 mutant, but not in those infected
with a Dstp1 mutant (Fig. 4C). These data emphasize the
importance of Stp1 and Stk1 for S. aureus virulence and abscess
formation.
The differences in survival and renal abscesses observed in the
mice infected with the Dstp1 and Dstk1 strains prompted us to
compare bacterial spread and cytokine responses during infection.
Six week-old female C57BL/6J mice (n = 5) were inoculated
intravenously with 16107 colony-forming units (CFU), and
kidneys, spleen and brain were harvested at 5 days post-infection
as described [69]. We observed that the bacterial CFU in the
kidneys, spleen and brain of mice infected with the WT, Dstp1 or
Dstk1 strains were not significantly different at 5 days post-infection
(Fig. 5, A–C). These results indicate that the attenuated virulence
of Dstp1 is not due to decreased survival or dissemination within
the host. A comparison of the host inflammatory response to
infection revealed a two-fold decrease in IL-6 production in the
kidneys of mice infected with the Dstp1 strain compared to kidneys
of mice infected with the Dstk1 strain (Fig. 6A). We did not observe
significant changes in KC (the murine functional homologue of IL-
8) and IL-1b production. A two-fold decrease in IL-6 expression
was also observed when bone marrow-derived macrophages
(BMMW) of C57BL/6 mice were stimulated with the Dstp1
mutant, compared to the Dstk1 strain (Fig. 6B). These studies
indicate that the staphylococcal serine/threonine kinase and
phosphatase affect the IL-6 response to S. aureus infection.
Phosphopeptide enrichment analysis
To identify potential substrates of Stk1, we performed in vivo
phosphopeptide enrichment and mass spectrometric analysis on
total proteins isolated from WT Newman and the isogenic Dstk1
strain as described previously [70] with a few modifications (see
Methods). Phosphopeptides (i.e. peptides that showed neutral loss
of phosphate during collision induced dissociation, CID) corre-
sponding to Stk1, DNA binding histone like protein (HU), serine-
aspartate rich fibrinogen/bone sialoprotein binding protein (SdrE)
and a hypothetical protein (NWMN_1123) were identified in the
WT and not in the Dstk1 mutant (Table 6, Fig. 7A–C). These data
suggest that Stk1 phosphorylates HU, SdrE and NWNM_1123 in
S. aureus. As phosphopeptides corresponding to a NAD-specific
glutamate dehydrogenase (GudB), pyruvate kinase (Pyk), anti-
sigma B factor antagonist (RsbV), threonyl-tRNA synthetase
(ThrS) and an acetyltransferase (NWNM_2273) were identified
in both WT and the Dstk1 mutant (Table 6), phosphorylation of
these proteins are likely to be independent of Stk1. Collectively,
these studies suggest that post-translational regulation of HU,
SdrE and NWNM_1123 by Stk1 and Stp1 affects S. aureus gene
expression and virulence.
Cell morphology, antibiotic resistance or growth in
minimal media
Recently Beltramini et al. reported that an stk1 mutant derivative
of S. aureus N315 was more susceptible to cell wall-acting
antibiotics and showed morphological changes such as incomplete
septa and irregular cell size, whereas an stp1 mutant had increased
peptidoglycan (PG, [71]). In contrast to these findings, we
observed no significant differences in the sensitivity of WT
Newman, Dstk1 and Dstp1 strains to the cell wall-acting antibiotics
imipenem, ceftriaxone and the fluoroquinolone ciprofloxacin
(MIC = 0.047, 4 and 0.125 mg/mL, respectively). Furthermore,
cross-sectional TEM did not reveal any irregularities in PG
thickness or cell shape of these strains (Fig. S1).
Other studies have suggested that Stk1 phosphorylates PurA
(adenylosuccinate synthase) in S. aureus strain 8325 to regulate
purine biosynthesis [72]. To determine whether Stk1 and Stp1 are
important for purine biosynthesis in S. aureus Newman, we
compared the ability of WT, Dstk1 and Dstp1 strains to grow in
chemically defined media (CDM) with or without exogenous
purines and/or pyrimidines as described [73]. The Dstk1 and Dstp1
mutants did not exhibit any significant differences during growth
in chemically defined media (CDM) supplemented with purines
and pyrimidines, CDM supplemented only with either purines or
pyrimidines, and CDM lacking both purines and pyrimidines (see
Fig. S2). As expected, the control strain with the transposon
Tn5EZ insertion in purA was unable to grow in the absence of
exogenous purines (Fig. S2) and was also avirulent in the mouse
sepsis model of infection (data not shown). The apparent
differences in the roles of Stk1 and Stp1 may be due to differences
in target substrates in S. aureus strains.
Discussion
In recent years, invasive infections due to S. aureus have
escalated in hospital and community settings. The importance of
hemolysins such as a toxin to S. aureus virulence has been
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Figure 4. Stp1 is important for virulence of S. aureus. (A) Ten, six week-old female C57BL/6J mice were intravenously injected with 2–56107
CFU of S. aureus WT, Dstp1 or Dstk1 strains. As a control, ten mice were inoculated in parallel with PBS. Kaplan-Meier survival curves show the percent
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extensively characterized. Given that S. aureus commonly resides as
a commensal in the nasal passages and gastrointestinal tract but is
also capable of invading deeper tissues, the pathogen must
appropriately express hemolysins and other virulence factors in
response to its external environment. To identify novel regulators
of the hemolysins, we screened a transposon insertion library for
mutants that showed altered toxin expression. Our studies
identified 72 genes that affect the hemolytic activity of S. aureus.
While some of the identified genes include previously established
regulators such as agr, sae, rot and ccpA, we also identified novel
genes that repress or activate the expression of S. aureus hemolytic
toxins. Notably, insertions in a putative cyclic di-GMP synthetase
decreased hemolysin expression, whereas insertions in purine
biosynthetic enzymes, a LysR family transcriptional regulator and
a serine/threonine kinase enhanced hemolysin expression. Given
that spontaneous mutations in the agr locus have been associated
with changes in hemolysin expression in S. aureus, we confirmed
that agr mutations are not responsible for the hemolysin
phenotypes of the Nemwam Dstp1 and Dstk1 mutants. Although
similar studies need to be performed with the other genes
identified in this study, a few loci that were identified as regulators
of toxin expression such as lipoamide dehydrogenase (SA1563),
dihydrodipicolinate synthase (dapA) and phosphoribosylformylgly-
cinamidine synthase (purL) were previously identified in screens for
S. aureus mutants that showed virulence attenuation [74,75,76,77].
Signal transduction in bacteria classically involves the reversible
phosphorylation of histidine residues, whereas phosphorylation of
serine/threonine residues was originally described in eukaryotes.
However, examples of eukaryotic-type serine/threonine phosphor-
ylation are increasingly encountered in bacteria. Previous studies
from our laboratory have indicated that a serine/threonine kinase
regulates hemolysin expression in Group B Streptococcus [60,61].
Therefore, we further characterized the role of the kinase Stk1 and
its cognate phosphatase Stp1 in the regulation of S. aureus hemolysin
expression and virulence. As the S. aureus strain RN4220 used to
construct the transposon library is not virulent, we evaluated the
effect of transposon insertions in stk1 and stp1 in a virulent WT S.
aureus strain. A comparison of hemolysin expression in the mutant
strains revealed that Stk1 negatively affects transcription of a toxin
whereas the phosphatase Stp1 promotes a toxin expression in
virulent S. aureus Newman. The identification of a phosphopeptide
corresponding to the DNA binding histone like protein (HU)
suggests that S. aureus modulates the function of HU for regulation of
gene expression similar to histone phosphorylation in eukaryotes
[78,79]. It has also been suggested that HU binding introduces
structural changes to the DNA which can facilitate or inhibit the
binding of regulatory proteins to their specific sites. Recently in E.
coli, HU was described to regulate the expression of ,8% of the
genome [80]. As hla transcription is decreased in Dstp1 and
increased in Dstk1, we predict that HU may regulate hla
transcription in S. aureus. Likewise, changes in gene expression
observed in the Dstp1 and Dstk1 strains could also be attributed to
altered HU function. In S. aureus, HU is encoded by the gene hsa and
is essential for growth [81]. Further studies to identify all genes that
are directly regulated by HU are being pursued and will reveal the
role of post translational regulation of HU in S. aureus.
Given the importance of S. aureus adherence to extracellular
matrix components, we hypothesize that the increase and decrease
in kidney abscesses observed with the Dstk1 and Dstp1 strains may, in
part, be linked to reversible phosphorylation of SdrE. SdrE is a
member of the family of surface proteins with serine (S)–aspartate
(D) repeats (R), and also includes SdrC, SdrD and clumping factors
(ClfA and ClfB). These proteins belong to a sub-family of adhesins
that specifically bind extracellular matrix molecules and are also
known as microbial surface components recognizing adhesive
matrix molecules (MSCRAMM, [82,83]). Although an exact
molecular function for SdrE is not known, it is proposed to bind
host extracellular matrix components and has been shown to
contribute to platelet aggregation [84,85]. Immunization with the
cell surface proteins SdrD and SdrE along with two other antigens
generated significant protective immunity [84]. Furthermore, S.
aureus with an sdrE-positive gene profile are associated with bone
infections [83]. Further studies to understand the role of
phosphorylation on SdrE function and S. aureus abscess formation
and virulence are being pursued. Likewise, similar studies to
understand the role of the hypothetical protein NWNM_1123 are
also being investigated to establish the role of phosphorylation of the
Stk1 targets in regulation of gene expression and S. aureus virulence.
In contrast to our findings, Beltramini et al recently concluded
that Stp1 and Stk1 do not regulate hemolysin expression in the
methicillin resistant S. aureus (MRSA) strain N315 [71]. However,
the role of either Stp1 or Stk1 in the virulence of strain N315 was
not examined [71]. Recently, stk1 mutations generated in S. aureus
strain SH1000 showed attenuated virulence which was attributed to
purine auxotrophy [72,86]. In contrast, we observed that Stp1 and
Stk1 are dispensable for purine biosynthesis in S. aureus Newman
(Fig S2), and a Dstk1 mutation does not attenuate virulence in this
strain background (Fig. 4). Collectively, these observations suggest
that Stk1 and Stp1 may mediate the phosphorylation of different
targets in S. aureus strains Newman, N315 and SH1000. Identifi-
cation of the in vivo Stk1 substrates in N315 and SH1000 will
elucidate the role of serine/threonine phosphorylation in these S.
aureus strains. Although the strain Newman has been extensively
used to study S. aureus pathogenesis, recent studies have indicated
the presence of a missense mutation in the sensor histidine kinase
SaeS that affects downstream gene regulation [87,88] Consequent-
ly, evaluation of the role of Stk1 and Stp1 in hemolysin expression
and S. aureus virulence in clinical isolates such as those of the
USA300 lineage, are in progress in our laboratory and, will provide
further significance to our observations in S. aureus Newman.
In this study, we have also identified a number of novel genes
encoding a putative LysR family transcription factor and a
putative cyclic di-GMP synthetase that regulate hemolysin
expression in S. aureus. Further characterization of these loci will
establish novel mechanisms by which the expression of exotoxins
and other S. aureus virulence genes are regulated.
survival of mice after the infection. Note that 100% of mice infected with the WT and Dstk1 strains succumbed to infection, in contrast to only 10% of
mice infected with the Dstp1 mutant. Survival of mice infected with the Dstp1 mutant was significantly different from that of the WT and the Dstk1
mutant (P value,0.0001, log rank test). However, mice infected with the Dstk1 mutant did not show a significant difference in survival compared to
the WT (P value = 0.44, log rank test). (B) Kidneys harvested from the mice that were moribund or at the end of the experiment. Arrows represent
abscesses that were observed on the infected kidneys. Note that a large number of abscesses are seen in the kidneys of mice infected with the Dstk1
mutant in comparison to those infected with the Dstp1 strain. One representative from ten infected kidney pairs after inoculation with the S. aureus
strain is shown. (C) Histological examination of infected renal tissue was performed at 5 days post-infection. Kidneys were fixed in formalin,
embedded in paraffin, thin-sectioned, stained with hematoxylin and eosin (H&E), and examined by microscopy as described previously [69,97].
Abscesses and necrotic tissue are observed in kidneys of mice infected with WT and Dstk1 strains but not with the Dstp1 mutant.
doi:10.1371/journal.pone.0011071.g004
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Methods
Ethics Statement
All animal experiments were approved by the Institutional
Animal Care and Use Committee of Seattle Childrens Research
Institute (IACUC protocol # 08-0515) and performed using
accepted veterinary standards.
Bacterial strains and growth conditions
A S. aureus RN4220 random transposon library containing 6,725
individual Tn5EZ mutants and the location of the these insertions
were kindly provided by Novartis Vaccines and Diagnostics (CMCC
#51963, see patent WO/2004/018624 entitled ‘Random transpo-
son insertion in Staphylococcus aureus and use thereof to identify esse-
ntial genes’ at http://www.wipo.int/pctdb/en/wo.jsp?WO = 2004%
2F018624&IA = WO2004%2F018624&DISPLAY = DESC). All oth-
er strains, plasmids and primers used in this study are listed in Table S1.
S. aureus strains were cultured in Tryptic Soy Broth (Difco Laboratories,
Detroit, MI) at 37uC unless indicated otherwise. The WT S. aureus
strains used in this study are RN4220 and Newman. Newman is a
clinical isolate of S. aureus that belongs to the capsular polysaccharide
serotype 5 and is routinely used in virulence studies [8,21,69,89,90].
Routine cultures of E. coli were performed in Luria-Bertani broth
(Difco Laboratories, Detroit, MI) at 37uC. Cell growth was monitored
by reading optical density at 600 nm. Antibiotics were added at the
Figure 5. Stp1 and Stk1 do not regulate in vivo proliferation of
S. aureus. Five, six week old female C57Black6 mice were intravenously
injected with 16107 CFU of WT, Dstp1 or Dstk1 strains. At approximately
5 days post-infection, kidneys, spleen, and brains were harvested from
infected mice and bacterial CFU enumerated. Note that the CFU of WT,
Dstp1 or Dstk1 S. aureus were not significantly different in the kidneys
(A), spleens (B) or brains (C) of infected mice.
doi:10.1371/journal.pone.0011071.g005
Figure 6. Stp1 and Stk1 regulate the host immune response to
S. aureus Newman. (A) Cytokine IL-6 levels were measured in kidney
homogenates obtained from infected mice at 5 days post-inoculation.
IL-6 levels were significantly lower in kidneys obtained from Dstp1
mutant-infected mice compared to Dstk1 mutant-infected mice (P
value = 0.003). (B) Bone marrow derived macrophages (BMMW) were
stimulated with WT, Dstp1 or Dstk1 S. aureus cells and cytokine IL-6
levels measured as described in the Methods. Secretion of IL-6 was
increased in response to S. aureus Dstk1 in comparison to Dstp1 or WT
(P value = 0.04). The experiment was repeated three times and similar
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following concentrations when necessary: for E.coli, ampicillin 100 mg/
mL, kanamycin 50 mg/mL, erythromycin 300 mg/mL, chloramphen-
icol 10 mg/mL; for S. aureus, kanamycin 50–100 mg/mL, erythromycin
1–5 mg/mL and chloramphenicol 10 mg/mL. All chemicals were
purchased from Sigma-Aldrich (St. Louis, MO), and molecular biology
reagents were purchased from New England Biolabs or Promega
Corporation, USA.
Construction of S. aureus allelic exchange mutants
Approximately 1kb of DNA flanking the 59 and 39 ends of stp1
or stk1 were PCR-amplified from S. aureus Newman using High
fidelity PCR (Invitrogen CA, USA). The primer pairs used to
amplify 1kb regions located upstream and downstream of stp1
were SAStp1000upF and SaSTP1000upCatR, and SaSTKco-
dingCatF and SAStkcodingR2, respectively. Likewise, the primer
pairs used to amplify 1kb regions located upstream and
downstream of stk1 were PSAF3 and SAstpnewKanR, and
PSAF2+ and PSAR4, repectively. For allelic replacement of stp1,
the gene conferring chloramphenicol (cm) resistance was amplified
from the plasmid pDC123 [64] using the primers SA-CatF and
SA-CatR. For alleic replacement of stk1, the gene conferring
kanamycin (kn) resistance was amplified from pCIV2 [65] using
the primers SA-KanF and SA-KanR. Subsequently, SOEing PCR
[91] was performed to introduce the antibiotic resistance gene (cm
or kn) between the flanking regions of stp1 or stk1. The PCR
fragments were then ligated into the temperature sensitive vector
pHY304, [92]) and the resulting plasmids pKB8 (Dstp1::cm) and
pKB1 (Dstk1::kn) were electroporated into S. aureus strain RN4220
using methods described previously [69]. Selection for single
crossovers and screening for the double crossovers was performed
as described [60,69]. PCR was used to verify the presence of the
allelic replacement cassette and the absence of the gene of interest.
Subsequently, the above mutations were transduced into the
virulent S. aureus wild type (WT) strain Newman using phage phi11
(w11) as described [62]. PCR was used to verify the presence of the
allelic replacement cassette in the region of interest in S. aureus
Newman. Complemented strains were constructed using the
vector pDCerm [93]. The genes encoding stp1 and stk1 were
amplified using the primers SaStpBamHIR and SaStpEcoRIF for
stp1, and pDCSaStkBamHIR and pDCSaStkEcoRIF for stk1, and
ligated into pDCerm to generate pStp1 and pStk1, respectively
(Table S1).
Quantitative western blots
S. aureus WT Newman and isogenic mutants were grown in TSB
to post-exponential phase (OD600,3.0). The cells were centrifuged
and secreted proteins were precipitated from cell-free supernatants
using 25% TCA as described previously [21]. Cell pellets were
disrupted using the FastPrep FP101 bead beater (Bio 101) and
centrifuged to remove unlysed cells and cell debris. Intracellular or
cytoplasmic proteins were quantified in the supernatants using the
Bradford protein assay [94]. Equal amounts of secreted or
cytoplasmic proteins (40mg) from each strain were subjected to
4–12% SDS-PAGE (Invitrogen NuPAGE). One mg of purified a
toxin (Sigma Chemical Co., USA) was included as a positive
control. Following electrophoresis, the proteins were transferred to
a PVDF membrane as described [94]. The membrane was
blocked in Odyssey buffer (Licor, USA) containing 5% normal
goat serum. Subsequently, a toxin antibody (Sigma Chemical Co.,
USA) was added at a 1:10,000 dilution followed by secondary
Alexa Fluor goat anti-rabbit antibody (Invitrogen) at 1:10,000.
Washes and imaging were performed as per manufacturer’s
instructions for the Odyssey Licor infrared imager.
Isolation and purification of total RNA.
Total RNA was isolated using the RNeasy Mini kit (QIAGEN,
Inc., Valencia, CA). In brief, S. aureus strains were grown to an
OD600 of 0.6 or ,3.0, centrifuged, and washed in 1:1 mixed RNA
Protect and TE buffer (QIAGEN, Inc., Valencia, CA). The cells
were then resuspended in RLT buffer (QIAGEN, Inc., Valencia,
CA) and lysed using a FastPrep FP101 bead beater (Bio 101) with
3630 s bursts at a power setting of 6, followed by centrifugation.
Table 6. S. aureus phosphopeptides identified using in vivo phosphopeptide enrichment and mass spectrometry.
Phosphopeptides unique to S. aureus WT Newman
Locus Phosphopeptide Protein Description Strain
WT Dstk1
NWMN_1123 PLMTEKSFT*NSK Hypothetical protein 6
HU INAVAEQADLT*K DNA-binding protein HU 6
SdrE GGLKDGETYT*VK Ser-Asp rich fibrinogen/bone sialoprotein-binding
protein,
6
SdrE TENNS*TNP Ser-Asp rich fibrinogen/bone sialoprotein-binding
protein
6
Stk1 ALSETSLTQT*NHVLGTVQYFSPEQAK Serine/threonine kinase 6
Phosphopeptides present in S. aureus WT Newman and the Dstk1 mutant
GudB DS*FGTVTNLFEETISNK NAD-specific glutamate dehydrogenase
Pyk ALGLITEENGIT*SPSAIVGLEK Pyruvate kinase
RsbV MDS*TGLGLFVGTLK Anti-sigma B factor antagonist
ThrS IGKELELFTNS*QLV Threonyl-tRNA synthetase
NWMN_2273 MVKVT*YDIPTCEDY Acetyltransferase, GNAT family protein
#Peptides listed above showed neutral loss of phosphoric acid in the LC/MS analysis. The serine or threonine residue that is phosphorylated is indicated as S* or T*,
respectively. A ‘ ’ indicates that the phosphopeptide was identified in the mass spectrometric analysis from the corresponding strain. A ‘6’ indicates that the
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RNA was isolated from the supernatants using the RNeasy Mini
kit as described by the manufacturer (QIAGEN, Inc., Valencia,
CA). RNA concentration and integrity was determined using an
Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA) and a
NanoDrop 1000 (NanoDrop, Wilmington, DE) for subsequent use
in qRT-PCR and microarray.
Quantitative Real-Time Reverse Transcription PCR (qRT-
PCR)
RNA isolated from three independent biological replicates for
each strain was purified as described above. qRT-PCR was
performed using a two-step QuantiTect SYBR Green RT-PCR kit
(QIAGEN, Inc., Valencia, CA) following the manufacturer’s
instructions for a total reaction volume of 20 mL (iCycler
thermocycler; Bio-Rad, Hercules, CA). cDNA synthesis was
achieved using 50 ng of total RNA, and PCR amplification was
performed as recommended by the manufacturer (Qiagen, USA).
All runs were immediately followed by a melting curve analysis to
evaluate PCR specificity and showed single primer-specific melting
temperatures. All assays were performed with at least three
independent biological replicates and three technical replicates for
each gene. All primers were calculated using Primer3 ser-
vices (http://frodo.wi.mit.ed/cgi-bin/primer3_www.cgi), pur-
chased from Integrated DNA Technologies (Coralville, IA) or
Sigma Chemical Company, and are listed in Table S1. The
housekeeping gene rpoD was used to normalize transcript
measurements, and relative gene expression calculated using the
comparative CT method [68]. Statistical significance was deter-
mined students t test as described previously [61].
Microarray
For microarray analysis, RNA was isolated from two indepen-
dent biological replicates of each strain as described above.
Purified RNA was sent to NimbleGen Systems, Inc. (Madison, WI)
for full expression services. NimbleGen performed: cDNA
synthesis, labeling of the cDNA, and hybridization of the labeled
cDNA to the Staphylococcus aureus COL custom chip (090327_
Saur_COL_SACOL1232_Expr_X4; NimbleGen Systems, Inc.
Figure 7. MS spectra of threonine phosphorylated peptides corresponding to SdrE (A), NWNM_1123 (B) and DNA binding protein
HU (C). The mass spectra show neutral loss of phosphoric acid from phosphopeptides that were unique to WT Newman (i.e. not detected in the
Dstk1 mutant). (A) the m/z of the doubly charged precursor ion corresponding to SdrE is 852.35144. Note that the peak depicting neutral loss of
phosphoric acid (H3PO4) has an m/z of 803.2118 due to the loss of 49 Da from the doubly charged peptide. (B) Likewise, the peak depicting neutral
loss of phosphoric acid (H3PO4) from the precursor ion corresponding to NWNM_1123 has an m/z of 796.1317 due to the loss of 49 Da from the
doubly charged peptide. (C) Note that the peak depicting neutral loss of phosphoric acid (H3PO4) has an m/z of 742.6785 due to the loss of 49 Da
from the doubly charged peptide corresponding to DNA binding protein HU.
doi:10.1371/journal.pone.0011071.g007
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Madison, WI) as per company protocols. The chips were
composed of 9 probes per target sequence, and each probe was
replicated three times (http://www.nimblegen.com/products/
exp/prokaryotic.html). Microarray data was interpreted, analyzed
and statistically evaluated using the program GeneSpring GX
(GeneSpring GX 7.3.1; Agilent Technologies, Santa Clara, CA).
All fold changes were defined relative to the Newman WT strain.
All data is MIAME compliant and that the raw data has been
deposited in a MIAME compliant database (GEO, accession
number GSE21426), as detailed on the MGED Society website
http://www.mged.org/Workgroups/MIAME/miame.html.
Virulence Assay
All animal experiments were approved by the Institutional
Animal Care and Use Committee of Seattle Childrens Research
Institute and performed using accepted veterinary standards.
The S. aureus WT strain Newman and isogenic mutants were
used for analysis of virulence as described previously [69,89,90].
Briefly, approximately 2–56107 CFU of each S. aureus strain was
injected via the tail vein into 6 week-old female C57BL/6J
mice (n = 10) purchased from Jackson Laboratories (Bar Harbor,
ME). Infected mice were monitored every 12 hrs for signs of
morbidity. Kidneys were obtained from mice that were
moribund or at the end of an experiment, visually examined
for abscess formation, and homogenized for CFU enumeration.
To compare CFU between WT, Dstp1 and Dstk1 strains, 16107
CFU of each S. aureus strain was injected via the tail vein into 6
week-old female C57BL/6J mice (n = 10), and spleen, kidneys
and brain were harvested from infected mice (n = 10 per group) 5
days after infection. Bacterial CFU were enumerated from the
homogenized tissue of five mice by plating serial 10-fold dilutions
on TSB agar. Kidneys from the remaining mice (n = 5) were
fixed in formalin, embedded in paraffin, thin-sectioned, stained
with hematoxylin and eosin (H&E) and examined by microscopy
as described previously [69].
Host immune response
IL-6 ELISA assays were performed on kidney homogenates
from above using the DuoSetH kit as described by the
manufacturer (R&D Systems, USA). Bone marrow derived
macrophages (BMMW) were derived as described previously [95]
with some modifications. Briefly, for each experiment, femurs were
excised from three C57BL/6J mice and bone marrow cells were
flushed, washed and resuspended using complete medium
(RPMI+20% fetal calf serum+L-Glutamine (2mM)). Two million
bone marrow cells were then differentiated into macrophages
using 20 ml complete medium supplemented with murine 40 ng/
ml rM-CSF (PeproTech). Cells were harvested between days 7–10,
at which point .99% of the cells were F4/80 Antigen+. BMMW
were transferred to 96-well plates (76104 cells in 200 ml medium/
well) and stimulated with WT, Dstp1 or Dstk1 cells for 24h at MOI
of 1. Supernatants were collected and stored at 280uC for ELISA
assays. IL-6 ELISA assays were performed using the DuoSetH kit
as described by the manufacturer (R&D Systems, USA). All
experiments were repeated three times in triplicate.
Statistical analysis
The Mann-Whitney test was used to evaluate differences
between cytokine levels and CFU/organ between S. aureus strains.
Survival analyses were performed using a log rank test. These tests
were performed using GraphPad Prism version 5.00 for Windows,
GraphPad Software, San Diego California USA, www.graphpad.
com.
Phosphopeptide enrichment and Mass spectrometry
Total protein was isolated from WT Newman and Dstk1 mutant
as described previously [70] with a few modifications. Briefly, each
sample was normalized to contain equal amount of protein and
the proteins were denatured and reduced in 10mM DTT
containing 0.1% Rapigest (Waters, USA) at 50uC for 30 min.
Subsequently, the reduced cysteines were alkylated with 30mM
iodoacetamide for 1hr in the dark and the samples were digested
overnight at 37uC using sequencing grade trypsin (1:100,trypsin:-
total protein). Rapigest was removed and samples were desalted
using Sep-Pak C-18 columns according to manufacturer’s
instructions (Waters, USA) and dried using a Speedvac. From
the peptide samples of each strain (500mg), phosphopeptides were
enriched and captured using soluble nanopolymer (PolyMAC) as
described previously [96]. Unbound non-phosphopeptides were
washed and phosphopeptides were eluted as described previously
[96]. The samples were analyzed by capillary liquid chromatog-
raphy- nanoelectrospray tandem mass spectrometry (mLC-na-
noESI-MS/MS) using a high resolution hybrid linear ion trap
orbitrap (LTQ-Orbitrap Velos, Thermo Fisher) coupled with
Eksigent Ultra2D nanoflow HPLC and methods described
previously [70,96]. Data were searched using Proteome Discover-
erTM software with SequestTM algorithm at 10 ppm precursor
mass accuracy cuttoff. The searches included static modification
on Cys residues (+57.0214), and variable modifications on
methionine (+15.9949) and Ser and Thr residues (+79.997) to
identify phosphorylation as described previously [70,96]. Spectra
were searched against the S. aureus strain Newman database
(NC_009641) with a 5% FDR cutoff based on the reverse database
decoy search using methods described [96]. The experiment was
performed using two independent biological replicates of each
strain.
Supporting Information
Figure S1 Cell morphology of stp1 and stk1 mutants is similar to
the WT S. aureus Newman. Cross sectional transmission electron
micrographs shown are at a magnification of 100,000. Arrows
show regions of PG that are marked with a line of the same size
across the three panels. Significant differences in cell morphology
or thickness of peptidoglycan are not apparent between WT
Newman and isogenic stp1 and stk1 mutants.
Found at: doi:10.1371/journal.pone.0011071.s001 (0.91 MB
DOC)
Figure S2 Stp1 and Stk1 are dispensable for purine and
pyrimidine biosynthesis of S. aureus Newman. S. aureus strains
were grown in chemically defined media (CDM) at 37uC and cell
growth was monitored every half hour. The OD600 of the strains
after 5 hrs of growth is shown. CDM was prepared as described
(Richardson et al., 2006, Molecular Microbiology 61: 927–939).
‘Complete CDM (cCDM)’ represents CDM containing exogenous
purines (adenine, guanine and xanthine) and the pyrimidine
(uracil). ‘Deleted CDM (dCDM)’ represents CDM lacking both
purines and pyrimidines. ‘dCDM + Purines’ represents CDM that
had the purines (adenine, guanine and xanthine) but did not
contain pyrimidines. ‘dCDM + Pyrimidines’ represents CDM that
was supplemented only with uracil and lacked purines. Note that
the control strain with a transposon insertion in purA showed no
growth in media lacking purines. Growth and doubling time of the
stp1 and stk1 mutants was comparable to WT S. aureus Newman.
Found at: doi:10.1371/journal.pone.0011071.s002 (0.03 MB
DOC)
Table S1 Strains, Plasmids, and Primers.
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Found at: doi:10.1371/journal.pone.0011071.s003 (0.07 MB
DOC)
Table S2 Genes with altered expression in stp1 and stk1 mutants
at post-exponential phase.
Found at: doi:10.1371/journal.pone.0011071.s004 (0.25 MB
DOC)
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